Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence.

Song C, Phuengkham H, Kim YS, Dinh VV, Lee I, Shin IW, Shin HS, Jin SM, Um SH, Lee H, Hong KS, Jin SM, Lee E, Kang TH, Park YM, Lim YT.

Nat Commun. 2019 Aug 20;10(1):3745. doi: 10.1038/s41467-019-11730-8.

2.

Drug repositioning of TANK-binding kinase 1 inhibitor CYT387 as an alternative for the treatment of Gram-negative bacterial sepsis.

Lee SJ, Gharbi A, You JS, Han HD, Kang TH, Hong SH, Park WS, Jung ID, Park YM.

Int Immunopharmacol. 2019 Aug;73:482-490. doi: 10.1016/j.intimp.2019.05.051. Epub 2019 Jun 4.

PMID:
31173970
3.

Co-degradation of interferon signaling factor DDX3 by PB1-F2 as a basis for high virulence of 1918 pandemic influenza.

Park ES, Byun YH, Park S, Jang YH, Han WR, Won J, Cho KC, Kim DH, Lee AR, Shin GC, Park YK, Kang HS, Sim H, Ha YN, Jae B, Son A, Kim P, Yu J, Lee HM, Kwon SB, Kim KP, Lee SH, Park YM, Seong BL, Kim KH.

EMBO J. 2019 May 15;38(10). pii: e99475. doi: 10.15252/embj.201899475. Epub 2019 Apr 12.

PMID:
30979777
4.

Alveolar Macrophages Treated With Bacillus subtilis Spore Protect Mice Infected With Respiratory Syncytial Virus A2.

Hong JE, Kye YC, Park SM, Cheon IS, Chu H, Park BC, Park YM, Chang J, Cho JH, Song MK, Han SH, Yun CH.

Front Microbiol. 2019 Mar 12;10:447. doi: 10.3389/fmicb.2019.00447. eCollection 2019.

5.

Repositioning of the antipsychotic drug TFP for sepsis treatment.

Park JH, Park HJ, Lee SE, Kim YS, Jang GY, Han HD, Jung ID, Shin KC, Bae YM, Kang TH, Park YM.

J Mol Med (Berl). 2019 May;97(5):647-658. doi: 10.1007/s00109-019-01762-4. Epub 2019 Mar 8.

6.

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.

Park HJ, Jang GY, Kim YS, Park JH, Lee SE, Vo MC, Lee JJ, Han HD, Jung ID, Kang TH, Park YM.

J Immunother Cancer. 2019 Feb 28;7(1):60. doi: 10.1186/s40425-019-0539-7.

7.

A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells.

Kim YS, Park HJ, Park JH, Hong EJ, Jang GY, Jung ID, Han HD, Lee SH, Vo MC, Lee JJ, Yang A, Farmer E, Wu TC, Kang TH, Park YM.

Oncoimmunology. 2018 Aug 15;7(10):e1472187. doi: 10.1080/2162402X.2018.1472187. eCollection 2018.

8.

CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.

Byeon Y, Lee JW, Choi WS, Won JE, Kim GH, Kim MG, Wi TI, Lee JM, Kang TH, Jung ID, Cho YJ, Ahn HJ, Shin BC, Lee YJ, Sood AK, Han HD, Park YM.

Cancer Res. 2018 Nov 1;78(21):6247-6256. doi: 10.1158/0008-5472.CAN-17-3871. Epub 2018 Aug 16.

PMID:
30115698
9.

Phloretin as a Potent Natural TLR2/1 Inhibitor Suppresses TLR2-Induced Inflammation.

Kim J, Durai P, Jeon D, Jung ID, Lee SJ, Park YM, Kim Y.

Nutrients. 2018 Jul 5;10(7). pii: E868. doi: 10.3390/nu10070868.

10.

Nobiletin Inhibits CD36-Dependent Tumor Angiogenesis, Migration, Invasion, and Sphere Formation Through the Cd36/Stat3/Nf-Κb Signaling Axis.

Sp N, Kang DY, Kim DH, Park JH, Lee HG, Kim HJ, Darvin P, Park YM, Yang YM.

Nutrients. 2018 Jun 15;10(6). pii: E772. doi: 10.3390/nu10060772.

11.

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.

Kim GH, Won JE, Byeon Y, Kim MG, Wi TI, Lee JM, Park YY, Lee JW, Kang TH, Jung ID, Shin BC, Ahn HJ, Lee YJ, Sood AK, Han HD, Park YM.

Drug Deliv. 2018 Nov;25(1):1394-1402. doi: 10.1080/10717544.2018.1480672.

12.

Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production.

Park HJ, Lee SJ, Cho J, Gharbi A, Han HD, Kang TH, Kim Y, Lee Y, Park WS, Jung ID, Park YM.

J Nat Prod. 2018 Jun 22;81(6):1435-1443. doi: 10.1021/acs.jnatprod.8b00155. Epub 2018 May 31.

13.

Mycobacterium tuberculosis GrpE, A Heat-Shock Stress Responsive Chaperone, Promotes Th1-Biased T Cell Immune Response via TLR4-Mediated Activation of Dendritic Cells.

Kim WS, Jung ID, Kim JS, Kim HM, Kwon KW, Park YM, Shin SJ.

Front Cell Infect Microbiol. 2018 Mar 27;8:95. doi: 10.3389/fcimb.2018.00095. eCollection 2018.

14.

Transcription Factor KLF10 Constrains IL-17-Committed Vγ4+ γδ T Cells.

Kim G, Gu MJ, Kim SJ, Ko KH, Kye YC, Kim CG, Cho JH, Lee WK, Song KD, Chu H, Park YM, Han SH, Yun CH.

Front Immunol. 2018 Feb 28;9:196. doi: 10.3389/fimmu.2018.00196. eCollection 2018.

15.

JQ1, a BET inhibitor, controls TLR4-induced IL-10 production in regulatory B cells by BRD4-NF-κB axis.

Lee MB, Lee JH, Hong SH, You JS, Nam ST, Kim HW, Park YH, Lee D, Min KY, Park YM, Kim YM, Kim HS, Choi WS.

BMB Rep. 2017 Dec;50(12):640-646.

16.

Tyrosine kinase Fyn regulates iNOS expression in LPS-stimulated astrocytes via modulation of ERK phosphorylation.

Ko HM, Lee SH, Bang M, Kim KC, Jeon SJ, Park YM, Han SH, Kim HY, Lee J, Shin CY.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):1214-1220. doi: 10.1016/j.bbrc.2017.11.143. Epub 2017 Nov 26.

PMID:
29180007
17.

DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation.

Kim HS, Nam ST, Mun SH, Lee SK, Kim HW, Park YH, Kim B, Won KJ, Kim HR, Park YM, Kim HS, Beaven MA, Kim YM, Choi WS.

Nat Commun. 2017 Nov 15;8(1):1519. doi: 10.1038/s41467-017-01527-y.

18.

An Essential Role for TAGLN2 in Phagocytosis of Lipopolysaccharide-activated Macrophages.

Kim HR, Lee HS, Lee KS, Jung ID, Kwon MS, Kim CH, Kim SM, Yoon MH, Park YM, Lee SM, Jun CD.

Sci Rep. 2017 Aug 18;7(1):8731. doi: 10.1038/s41598-017-09144-x.

19.

Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells.

Sp N, Kang DY, Joung YH, Park JH, Kim WS, Lee HK, Song KD, Park YM, Yang YM.

Int J Mol Sci. 2017 Apr 30;18(5). pii: E935. doi: 10.3390/ijms18050935.

20.

Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity.

Kim SY, Noh YW, Kang TH, Kim JE, Kim S, Um SH, Oh DB, Park YM, Lim YT.

Biomaterials. 2017 Jun;130:56-66. doi: 10.1016/j.biomaterials.2017.03.034. Epub 2017 Mar 26.

PMID:
28364631

Supplemental Content

Loading ...
Support Center